Translator Disclaimer
1 March 2006 DH-I-180-3–Mediated Photodynamic Therapy: Biodistribution and Tumor Vascular Damage
Author Affiliations +
Abstract

An important goal of photodynamic therapy (PDT) for treatment of various cancers is to shorten PDT-performing time and simultaneously enhance PDT efficacy. Here, we investigated the nontumor tissue distribution of and the tumor vascular damage caused by a new photosensitizer, DH-I-180-3, in mice with implanted EMT6 mammary tumor cells. In addition, we performed cell-based assays to evaluate the basic antitumor effect of DH-I-180-3/PDT in EMT6 cells. After administration of PDT, the type of cell death was characterized to be apoptosis, and a change in the mitochondrial membrane potential was also observed within minutes. On the other hand, tumor growth was remarkably retarded in vivo in mice that received DH-I-180-3/PDT, compared with mice in the control group, which were exposed to light irradiation alone. Finally, tumors in some mice nearly healed. The antitumor drug reached a maximum concentration approximately 3 h after administration. However, PDT was most effective when there was substantial accumulation of DH-I-180-3 in the tumor vasculature and in healthy tissue. The histological demonstration provided further evidence of tumor vascular damage. On the basis of these findings, we suggest that PDT with the photosensitizer DH-I-180-3 induces vascular damage with blood vessel shutdown, in addition to direct killing of tumor cells, in mice.

Dae-Seog Lim, Si-Hwan Ko, Chang-Hee Lee, Woong-Shick Ahn, and Won-Young Lee "DH-I-180-3–Mediated Photodynamic Therapy: Biodistribution and Tumor Vascular Damage," Photochemistry and Photobiology 82(2), 600-605, (1 March 2006). https://doi.org/10.1562/2005-09-13-RA-683
Received: 13 September 2005; Accepted: 1 November 2005; Published: 1 March 2006
JOURNAL ARTICLE
6 PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top